Globela Pharma Private Limited — Ritonavir Exporter Profile
Indian Pharmaceutical Exporter · #10 for Ritonavir · $276.5K export value · DGFT Verified
Globela Pharma Private Limited is the #10 Indian exporter of Ritonavir with $276.5K in export value and 13 verified shipments. Globela Pharma Private Limited holds a 0.1% market share in Ritonavir exports across 2 countries. The company exports 9 pharmaceutical products worth $3.3M across 5 therapeutic categories.
Globela Pharma Private Limited — Ritonavir Export Profile: Buyers & Destinations
Where Does Globela Pharma Private Limited Export Ritonavir?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PERU | $126.3K | 12 | 95.8% |
| JORDAN | $5.5K | 1 | 4.2% |
Globela Pharma Private Limited exports Ritonavir to 2 countries. The largest destination is PERU accounting for 95.8% of Globela Pharma Private Limited's Ritonavir shipments. These destinations reflect Globela Pharma Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ritonavir from Globela Pharma Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| NORDIC PHARMACEUTICAL COMPANY SAC | PERU | $99.1K | 9 |
| NORDIC PHARMACEUTICAL CO SAC | PERU | $27.2K | 3 |
| GREEN LAND DRUUG STORE CO | JORDAN | $5.5K | 1 |
Globela Pharma Private Limited supplies Ritonavir to 3 buyers globally. The largest buyer is NORDIC PHARMACEUTICAL COMPANY SAC (PERU), followed by NORDIC PHARMACEUTICAL CO SAC (PERU) and GREEN LAND DRUUG STORE CO (JORDAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ritonavir Export Value and How Much Does Globela Pharma Private Limited Contribute?
India exported $69.2M worth of Ritonavir through 1,555 shipments from 84 suppliers to 155 countries, serving 525 buyers globally. Globela Pharma Private Limited contributes $276.5K to this total, accounting for 0.1% of India's Ritonavir exports. Globela Pharma Private Limited ships Ritonavir to 2 countries through 3 buyers.
What Is the Average Shipment Value for Globela Pharma Private Limited's Ritonavir Exports?
Globela Pharma Private Limited's average Ritonavir shipment value is $21.3K per consignment, based on 13 shipments totaling $276.5K. The largest destination is PERU (95.8% of Globela Pharma Private Limited's Ritonavir exports).
How Does Globela Pharma Private Limited Compare to Other Indian Ritonavir Exporters?
Globela Pharma Private Limited ranks #10 among 84 Indian Ritonavir exporters with a 0.1% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($27.5M), HETERO LABS LIMITED ($24.7M), EMCURE PHARMACEUTICALS LIMITED ($5.5M). Globela Pharma Private Limited processed 13 shipments to 2 destination countries.
What Ritonavir Formulations Does Globela Pharma Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| RITOPHAR PACK 120 Tablets RITONAVIR TA | $50.0K | 1 |
| RITOPHAR PACK 30 TAB RITONAVIR TABLETS USP 100 MG BATCH NO GT23605 MANUFACTURING DT 09/2023 EXP DT 08/2026 | $16.4K | 1 |
| RITOPHAR PACK 120 TABLETS RITONAVIR TABLETS USP 100 MG BATCH NO GT23105 MFGDT 01 2023 EXP DT 12 2025 | $16.0K | 1 |
| RITOPHAR (PACK 30 TAB) (RITONAVIR TABLETS USP 100 MG) (BATCH NO GT23666 MFG DT 11/2023 EXP DT 10/2026)NOS | $9.6K | 1 |
| RITOPHAR BOTTLE X 30 COATED TABLET RITONAVIR TABLETS USP 100 MG BATCH NO GT23605 MANUFACTURING DT 09/2023 EXP DT 08/2026 | $9.2K | 1 |
| RITOPHAR PACK 120 TABLETS RITONAVIR TABLETS USP 100 MG BATCH NO GT23104 MFGDT 01 2023 EXP DT 12 2025 | $8.0K | 1 |
| RITOPHAR (TENDER) (PACK 30 TAB) (RITONAVIR TABLETS USP 100 MG) (BATCH NO GT23666MFG DT 11/2023 EXP DT 10/2026)NOS | $7.0K | 1 |
| RITOPHAR (PACK 30 TAB) (RITONAVIR TABLETS USP 100 MG) (BATCH NO GT23667 MFG DT 11/2023 EXP DT 10/2026)NOS | $5.5K | 1 |
| RITOLOP (1X120 TAB BOT) (LOPINAVIR AND RITONAVIR 200 + 50 MG TABLETS USP) (BATCHNO GT24060 MFG DT 01/2024 EXP DT 12/202NOS | $5.5K | 1 |
| RITOPHAR PACK 120 Tablets RITONAVIR TABLETS USP 100 MG BATCH NO 23GT102 MFG DT 03 2023 EXP DT 02 2025 | $3.0K | 1 |
Globela Pharma Private Limited exports 13 distinct Ritonavir formulations including tablets, capsules, syrups, and combination drugs. The top formulation is RITOPHAR PACK 120 Tablets RITONAVIR TA with 1 shipments worth $50.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Globela Pharma Private Limited Compare to Nearest Ritonavir Exporters?
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | CIPLA LIMITED | $1.4M | 28 | 10 | $50.0K |
| 6 | EMCURE PHARMACEUTICALS LTD | $400.0K | 8 | 7 | $50.0K |
| 10 | GLOBELA PHARMA PRIVATE LIMITED ★ | $276.5K | 13 | 2 | $21.3K |
| 9 | LIVEALTH BIOPHARMA PRIVATE LIMITED | $200.0K | 4 | 2 | $50.0K |
| 11 | AAGAMA EXPORTS LLP | $193.0K | 5 | 1 | $38.6K |
Globela Pharma Private Limited ranks #10 among 84 Indian Ritonavir exporters. Average shipment value of $21.3K compared to the market average of $823.4K. The closest competitors by value are CIPLA LIMITED and EMCURE PHARMACEUTICALS LTD.
Which Indian Ports Ship Ritonavir Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 335 | 21.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 281 | 18.1% |
| HYDERABAD ACC (INHYD4) | 217 | 14.0% |
| HYDERABAD AIR | 123 | 7.9% |
| Bombay Air | 87 | 5.6% |
| NHAVA SHEVA SEA (INNSA1) | 58 | 3.7% |
| DELHI AIR CARGO ACC (INDEL4) | 48 | 3.1% |
| HYDERABAD ICD | 47 | 3.0% |
About Globela Pharma Private Limited
Globela Pharma Private Limited exports 9 products worth $3.3M. Beyond Ritonavir, top products include Fluconazole, Erythromycin, Febuxostat, Letrozole, Anastrozole. View the complete Globela Pharma Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ritonavir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ritonavir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Globela Pharma Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 13 individual customs records matching Globela Pharma Private Limited exporting Ritonavir, covering 13 formulations to 2 countries via 3 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 155+ countries, 525+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ritonavir Export Data from Globela Pharma Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Globela Pharma Private Limited's Ritonavir exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Globela Pharma Private Limited
Full Company Profile →
9 products · $3.3M total trade · 5 categories
Ritonavir Stats
Company Overview
Top Products by Globela Pharma Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Globela Pharma Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ritonavir. For current shipment-level data, contact TransData Nexus.